Amended Quarterly Report (10-q/a)

Date : 05/22/2019 @ 5:35PM
Source : Edgar (US Regulatory)
Stock : United Health Products, Inc. (PC) (UEEC)
Quote : 1.385  -0.015 (-1.07%) @ 8:59PM

Amended Quarterly Report (10-q/a)

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q/A

(Amendment No. 1)

 

x

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2019

 

¨

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ____________ to ____________

 

Commission file number: 000-27781

 

UNITED HEALTH PRODUCTS, INC.

(Exact name of Company as specified in its charter)

 

Nevada

 

84-1517723

(State or other jurisdiction of incorporation or organization)

 

(I.R.S. Employer Identification No.)

 

10624 S. Eastern Ave., Suite A209

Henderson, NV

 

89052

(Address of Company's principal executive offices)

 

(Zip Code)

 

(877) 358-3444

(Company's telephone number, including area code)

 

None

(Former name, former address and former fiscal year, if changed since last report)

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 the Securities Act. Yes ¨ No x

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ¨ No x

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No ¨

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

¨

Accelerated filer

¨

Non-accelerated filer

¨

Smaller reporting company

x

 

Emerging growth company

¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

 

The number of shares issued of the Registrant's Common Stock, as of May 15­, 2019 was 176,217,368 issued and  outstanding.

 

 
 
 
 

EXPLANATORY NOTE

 

The sole purpose of this Amendment No. 1 to the Quarterly Report on Form 10-Q for the quarter ended March 31, 2019 of United Health Products, Inc. (the “Company”) filed with the Securities and Exchange Commission on May 15, 2019 (the “Form 10-Q”) is to furnish updated Exhibits 101 to the Form 10-Q to correct typographical errors in the original filing. The cover page of the Form 10-Q has also been updated to correct typographical errors.
 
No other changes have been made to the Form 10-Q. This Amendment No. 1 to the Form 10-Q speaks as of the original filing date of the Form 10-Q, does not reflect events that may have occurred subsequent to the original filing date, and does not modify or update in any way disclosures made in the original Form 10-Q.
 
 

2

 
 

 

PART II

 

ITEM 6. EXHIBITS

 

Exhibit

Incorporated by Reference

Filed or

Furnished

Herewith

Number

Exhibit Description

Form

Exhibit

Filing Date

101.INS

XBRL Instance Document

x

101.SCH

XBRL Taxonomy Extension Schema Document

x

101.CAL

XBRL Taxonomy Extension Calculation Linkbase Document

x

101.DEF

XBRL Taxonomy Extension Definition Linkbase Document

x

101.LAB

XBRL Taxonomy Extension Label Linkbase Document

x

101.PRE

XBRL Taxonomy Extension Presentation Linkbase Document

x

 

 

3

 
 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this amended report to be signed on its behalf by the undersigned, thereunto duly authorized on May 22, 2019.

 

 

United Health Products, Inc.

 

By:

/s/ Douglas Beplate

 

Douglas Beplate

Principal Executive Officer

 

 

By:

/s/ Nate Knight

 

Nate Knight

 

Principal Financial Officer

 

 
4

 

United Health Products, Inc. (PC) (USOTC:UEEC)
Historical Stock Chart

1 Year : From Dec 2018 to Dec 2019

Click Here for more United Health Products, Inc. (PC) Charts.

United Health Products, Inc. (PC) (USOTC:UEEC)
Intraday Stock Chart

Today : Monday 9 December 2019

Click Here for more United Health Products, Inc. (PC) Charts.

Latest UEEC Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.